Extra! Extra! Read all about it! New paper from the Hill Lab out now in Nature Communications! Myeloid-derived miR-6236 potentiates #adipocyte insulin signaling and prevents #hyperglycemia during #obesity. Read and share here: rdcu.be/dLS76

Excited to share our recent work on a GBS T7SS LXG toxin Alyx Job Doran Lab —now out in mBio!🎉

I am excited to share the latest work from the lab: Kristen Witt’s (Kristen Witt) discovery of a novel pathway of interferon regulation, the SP140-RESIST pathway. As a bonus, there is a fun connection to effector-triggered immunity as well (thread): biorxiv.org/content/10.110…

Hear from a talented lineup of immunologists next Wednesday, Sept 18 featuring Zuri Sullivan, Alex Wells, Djenet Bousbaine, Dr. Valeria M. Reyes Ruiz, Maria Cecilia Canesso, Dr Becs, Liwen Deng, & Nagela Ghabdan Zanluqui. Register: bit.ly/ScrippsLeaders

Calling all Enterococcal researchers & enthusiasts! 🦠We've really appreciated the Enterococcal tools available @Biocyc, especially with upgraded curation, so I'm happy to spread the good word to those who are still out there.

Paper out! Postdoc Matt Hackbart characterized non-standard viral genomes generated during arenavirus infections and identified prominent S RNA intergenic region deletions that can interfere with expression of the LCMV glycoprotein| mBio journals.asm.org/doi/10.1128/mb…

It’s difficult to wrap one’s mind around NIH’s decision to shut down the most important shared resource for work in many of the world’s most impactful infectious diseases. science.org/content/articl…

Shan Chandrakasan Children's, Ed Behrens Children's Hospital, et al. find out what happens when you stop being polite to #HLH/#MAS, and start getting REAL. #IFNG. acrjournals.onlinelibrary.wiley.com/doi/10.1002/ar…

We are hiring an Assistant Professor in Cancer Pathobiology at CHOP/Penn. This is a great opportunity to join the fantastic Penn community. Please apply & share. apply.interfolio.com/152601

THREE assistant professor positions in microbiology at Yale! (3/3) Microbe-Immune Interaction - Microbial Sciences Institute in partnership with Yale Department of Immunobiology apply.interfolio.com/152022, deadline 11/1/24 Please RT and apply!

Want to learn how to process 16S microbiome data, conduct analyses, & visualize results? Want to learn community-scale metabolic modeling? Want to hear talks from experts on the gut-brain axis? Register for the 2024 ISB Virtual Microbiome Series! isbscience.org/microbiome2024/

Critical loss: the effects of VEuPathDB defunding on global health - The Lancet Microbe ⁦parasitesrule⁩ ⁦ASTMH⁩ @nih ⁦NIAID News⁩ ⁦British Society for Parasitology⁩ ⁦Women In Parasitology⁩ ⁦Parasite Slack⁩ #mpm2024 thelancet.com/journals/lanmi…

Very cool to see Byndloss Lab graduate student Catie Shelton paper on the Best of Cell Host & Microbe 2023 list! Congrats, Catie! Such a rockstar!

Bacterial antimicrobial resistance, which is steadily increasing, looms as a major threat. This new Institute for Health Metrics and Evaluation (IHME) report The Lancet comprehensively reviews the past 3 decades and forecasts out to 2050. thelancet.com/journals/lance… open-access Much more needs to be done to avert tens of

By 2050, around 2 million people — the majority aged over 70 — could die from drug-resistant infections each year go.nature.com/4e8E9jO

The lab had an amazing time at Midwest Microbial Pathogenesis Conference (MMPC) this weekend in Bloomington, Indiana! So happy to be part of such a vibrant community of microbial pathogenesis in the Midwest! And congrats to postdoc Xiaomei Ren Xiaomei Ren on her abstract award 🎉 #MMPC2024

Tomorrow, join the Scripps Research virtual symposium featuring Zuri Sullivan, Alex Wells, Djenet Bousbaine, Dr. Valeria M. Reyes Ruiz, Maria Cecilia Canesso, Dr Becs, Liwen Deng, & Nagela Ghabdan Zanluqui. Please RT & register here: bit.ly/ScrippsLeaders

Got some inspiration from Arturo Casadevall and Victor J. Torres Alejandro Pironti !

We are excited to announce the publication of our new article today: nature.com/articles/s4158…

We are all living in a bubble that deprives us of experiences needed to understand the true magnitude of the threat posed by the rise of multi-drug resistant infections. It would be wise to allocate resources that match the severity of the threat. science.org/doi/10.1126/sc…